One-month therapy with simvastatin restores endothelial function in hypercholesterolemic children and adolescents

Pediatric Cardiology

Volumn 28, Issue 1, 2007, Pages 8-13

  Ferreira, Waldinai Pereira ^a,b,c   Bertolami, Marcelo Chiara ^a   Santos, Simone Nascimento ^a   Barros, Marcos Roberto A C ^a   De Matos Barretto, Rodrigo Bellio ^a   Pontes Jr , Sèrgio Cunha ^a   Fonseca, Francisco Hermann ^b   Carvalho, Antonio Carlos ^b  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

Cholesterol; Endothelium; Hypercholesterolemia

Indexed keywords

AMINOTRANSFERASE; APOLIPOPROTEIN B; CHOLESTEROL; CREATINE KINASE; FIBRINOGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ARTERY DIAMETER; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRACHIAL ARTERY; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DOPPLER FLOWMETER; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; ENDOTHELIAL DYSFUNCTION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HEART MUSCLE BLOOD FLOW; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MALE; PATIENT ASSESSMENT; PHYSICAL EXAMINATION; PROTEIN BLOOD LEVEL; SIDE EFFECT; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ANTILIPEMIC AGENTS; BRACHIAL ARTERY; CASE-CONTROL STUDIES; CHILD; CHOLESTEROL; ENDOTHELIUM; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; SIMVASTATIN; TIME FACTORS;

EID: 33847180214     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-005-1304-x     Document Type: Article

References (30)

1. Aggoun Y, Bonnet D, Sidi D, et al. (2000) Arterial mechanical changes in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 20:2070-2075
2. Alonso R, Mata P, De Andres R, et al. (2001) Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastatin. Atherosclerosis 157:423-429
3. Berenson GS, Srinivasan SR, Bao W, et al. (1998) Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 338:1650-1656
4. Celermajer DS, Sorensen KE, Gooch VM, et al. (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111-1115
5. De Caterina R, Lenzi S (1998) The role of LDL in the origin and progression of atherosclerosis: pathobiological concepts on the origin and development of atherosclerotic lesions and the role of the endothelium. G Ital Cardiol 28:158-167
6. de Jongh S, Lilien MR, Bakker HD, et al. (2002) Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia. Atherosclerosis 163:193-197
7. de Jongh S, Lilien MR, op't Roodt J, et al. (2002) Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol 40:2117-2121
8. de Jongh S, Ose L, Szamosi T, et al. (2002) Simvastatin in Children Study Group. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation 106:2231-2237
9. Gerber ZRS, Zielinsky P (1997) Risk factors of atherosclerosis in children. An epidemiologic study. Arq Bras Cardiol 69:231-236
10. Gordon T, Kannel WB, Castelli WP, Dawber TR (1981) Lipoproteins, cardiovascular disease, and death. The Framingham study. Arch Intern Med 141:1128-1131
11. Holman RL, McGill HC Jr, Strong JP, Geer JC (1958) The natural history of atherosclerosis: the early aortic lesions as seen in New Orleans in the middle of the 20th century. Am J Pathol 34:209-235
12. Jarvisalo MJ, Lehtimaki T, Raitakari OT (2004) Determinants of arterial nitrate-mediated dilatation in children: role of oxidized low-density lipoprotein, endothelial function, and carotid intima-media thickness. Circulation 109:2885-2889
13. Joannides R, Haefeli WE, Linder L, et al. (1995) Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91:1314-1319
14. Kadikoylu G, Yukselen V, Yavasoglu I, Bolaman Z (2003) Hemostatic effects of atorvastatin versus simvastatin. Ann Pharmacother 37:478-484
15. Laufs U, La Fata V, Plutzky J, Liao JK (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97:1129-1135
16. Leeson CP, Whincup PH, Cook DG, et al. (2000) Cholesterol and arterial distensibility in the first decade of life: a population-based study. Circulation 101:1533-1538
17. Makris TK, Hatzizacharias AN, Krespi PG, et al. (2003) Markers of risk in young offspring with paternal history of myocardial infarction. Int J Cardiol 89:287-293
18. Martinez-Gonzalez J, Llorente-Cortes V, Badimon L (2001) Cellular and molecular biology of atherosclerotic lesions. Rev Esp Cardiol 54:218-231
19. McCrindle BW, Ose L, Marais AD (2003) Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. J Pediatr 143: 74-80
20. McGill HC Jr, McMahan CA, Herderick EE, et al. (2000) Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr 72(5 Suppl):1307S-1315S
21. Newman WP 3rd, Freedman DS, Voors AW, et al. (1986) Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med 314:138-144
22. O'Driscoll G, Green D, Taylor RR (1997) Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95:1126-1131
23. Reddy KG, Nair RN, Sheehan HM, Hodgson JM (1994) Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 23:833-843
24. Reinhart WH (2003) Fibrinogen - marker or mediator of vascular disease? Vasc Med 8:211-216
25. Scandinavian Simvastatin Survival Group (2000) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383-1389
26. Singh TP, Groehn H, Kazmers A (2003) Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J Am Coll Cardiol 41:661-665
27. Wiegman A, de Groot E, Hutten BA, et al. (2004) Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia. Lancet 363:369-370
28. Wiegman A, Hutten BA, de Groot E, et al. (2004) Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. J Am Med Assoc 292:331-337
29. World Health Organization (1999) Report of a Second WHO Consultation. Geneva 1-23. WHO/HGN/FH/CONS/99.2
30. Zeiher AM, Drexler H, Wollschlager H, Just H (1991) Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83:391-401